Nanobiotix is developing nanotechnology products that could enhance radiotherapy, a cornerstone cancer treatment. The NanoXray technology consists of three products, which are based on physical properties rather than a biological effect, supported by preclinical data. The lead product NBTXR3 for direct tumour injection is currently in Phase I development, with additional data and progression into additional indications expected over the next 12-18 months.
Small particles loaded with medicine could be a future weapon for cancer treatment. A recently-published study shows how nanoparticles can be formed to efficiently carry cancer drugs to tumor cells. And because the particles can be seen in MRI ima...
Researchers have demonstrated a new technology that combines a laser and electric fields to create tiny centrifuge-like whirlpools to separate particles and microbes by size, a potential lab-on-a-chip system for medicine and research.
It may come as a surprise to the layman that after having built a massive sci-tech industry around our knowledge of the DNA, the molecular stuff of life, biochemists would, in 2012, be saying they have just photographed the molecule for the first...
Nanobiotix, announced today that the Independent Data Monitoring Committee (IDMC) has reviewed the data of the first 6 patients treated in the phase I Study with the lead product NBTXR3 for the treatment of advanced Soft Tissue...
Scientists at Royal Holloway have developed a pioneering new method of oral vaccination.
Lead scientist Professor Simon Cutting, from the School of Biological Sciences at Royal Holloway, has developed the method through the use of probiotic spores.
He carried out fundamental studies into the biology of the bacterium Bacillus subtilis which attracted the attention of microbiologists due to its ability to form spores that can last millions of years before germinating under the appropriate environmental conditions.
Nanotechnology X-ray Method Aims to Kill Cancer But Spare Healthy Tissue
“Development of this technology has involved many scientific disciplines beyond oncology: physics, chemistry, biophysics, cellular biology, radiobiology, molecular biology, physical chemistry, and others....
LONDON (Reuters) - Is nanomedicine the next big thing?
Laurent Levy's insight:
he ability to encapsulate potent drugs in tiny particles measuring billionths of a meter in diameter is opening up new options for super-accurate drug delivery, increasing precision hits at the site of disease with, hopefully, fewer side effects.
Cambridge University scientists say they have seen four-stranded DNA at work in human cells for the first time and wonder if it might provide a target for the development of novel anti-cancer treatments.
What dealing with the fiscal cliff has to do with inventing new Alzheimer's drugs.
Laurent Levy's insight:
At first glance, the fiscal cliff and promising new Alzheimer’s research don’t seem to have much in common. Yet, from my perspective leading one of the largest U.S.-based biopharmaceutical companies engaged in that research, they do indeed.
Imagine a field full of pyramids, but on a micro scale. Each of the pyramids hides a living cell. Thanks to 3-D micro- and nano-scale fabrication, this is possible and there are promising new applications in the offing.
Nature is the international weekly journal of science: a magazine style journal that publishes full-length research papers in all disciplines of science, as well as News and Views, reviews, news, features, commentaries, web focuses and more,...